Alegro announces update to Board of Directors at annual meeting



    TORONTO, June 25 /CNW/ - Alegro Health Corp. (TSX-V: AGO), a provider of
medical, rehabilitation and disability management services, announced the
election of directors following the Company's annual meeting, held this
morning at Alegro's corporate offices in Toronto. The board members are as
follows:
    Dr. Martin Barkin, Chairman of the Board, Brenda Rasmussen, President and
CEO of Alegro, Robert Wardell, who serves on the Board of several Canadian
publicly listed companies and was a Senior Audit Partner with Deloitte &
Touche LLP from 1986 to 2006, Tom Magyarody, Director and CEO of the Ontario
Dental Association, Dr. Jack Shevel, President of Global Healthcare
Investments & Solutions, Inc., and Darren Youngleson, Chief Financial Officer
of Global Healthcare Investments & Solutions, Inc. Alegro's largest
shareholder.

    About Alegro Health Corp.

    Alegro Health Corp. is a leading healthcare services company providing
select quality services through its Disability & Rehabilitation Management and
Surgical/Hospital Services divisions. Alegro is addressing the growing demand
for enhanced insured and uninsured healthcare services, as well as delivering
additional resources to Canadian public healthcare services through government
outsourcing. With superior knowledge of the healthcare industry, extensive and
trusted relationships with payers, physicians, and government agencies, Alegro
is pursuing a vertically integrated approach and an aggressive acquisition
strategy to achieve its growth objectives. Alegro is listed on the TSX Venture
Exchange under the symbol AGO. For further information, please visit
www.alegrohealth.com.

    This press release contains statements that may constitute
"forward-looking statements" within the meaning of applicable Canadian
securities legislation. These forward-looking statements include, among
others, statements regarding business strategy, plans and other expectations,
beliefs, goals, objectives, information and statements about possible future
events. Specific forward-looking statements contained in this press release
include statements regarding Alegro's proposed acquisition of Active Health,
the completion of the acquisition and the outcome of the acquisition, as well
as statements regarding transaction values, accretion, and ownership levels
resulting from the completion of the proposed acquisition. Readers are
cautioned not to place undue reliance on such forward-looking statements.
Forward-looking statements are based on current expectations, estimates and
assumptions that involve a number of risks, which could cause actual results
to vary and in some instances to differ materially from those anticipated by
Alegro and Active Health and described in the forward-looking statements
contained in this press release. Among the various factors that could cause
results to vary materially from those indicated in the forward-looking
statements include failure to realize anticipated synergies and the result of
the review of the proposed acquisition by regulatory authorities. No assurance
can be given that any of the events anticipated by the forward-looking
statements will transpire or occur or, if any of them do so, what benefits
Alegro will derive there from.

    
    This release was prepared by management of the Company who takes full
    responsibility for its contents. The TSX Venture Exchange has not
    reviewed and does not accept responsibility for the adequacy or accuracy
    of this news release.
    

    %SEDAR: 00016656E




For further information:

For further information: Brenda Rasmussen, President and CEO, Alegro
Health, (416) 927-8400 ext. 303, brasmussen@alegrohealth.com; Michael Moore,
Investor Relations, Equicom Group, (416) 815-0700 ext. 241,
mmoore@equicomgroup.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890